(Q48313903)

English

Oral probiotic treatment of Lactobacillus rhamnosus Lcr35® prevents visceral hypersensitivity to a colonic inflammation and an acute psychological stress.

scientific article published on 8 October 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27718511%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Oral probiotic treatment of Lactobacillus rhamnosus Lcr35® prevents visceral hypersensitivity to a colonic inflammation and an acute psychological stress (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27718511%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

0 references

Lactobacillus rhamnosus

object named as

Lactobacillus rhamnosus

1 reference

based on heuristic

inferred from title

psychological stress

1 reference

based on heuristic

inferred from title

Adrien Nivoliez

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27718511%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

author name string

Y Darbaky

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27718511%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

B Evrard

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27718511%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

S Patrier

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27718511%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

J Falenta

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27718511%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

S Garcin

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27718511%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

A Tridon

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27718511%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

M Dapoigny

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27718511%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

C Silberberg

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27718511%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

L Diop

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27718511%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

publication date

21 November 2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27718511%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Journal of Applied Microbiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27718511%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

122

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27718511%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27718511%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

188-200

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27718511%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Interferon lambda-3 polymorphism and response to pegylated interferon in patients with hepatitis D.

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Host immune response determines visceral hyperalgesia in a rat model of post-inflammatory irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

A marketed fermented dairy product containing Bifidobacterium lactis CNCM I-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats.

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: a possible action through interaction with epithelial cell cytoskeleton contraction

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Lactobacillus farciminis treatment attenuates stress-induced overexpression of Fos protein in spinal and supraspinal sites after colorectal distension in rats.

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats.

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

A role for inflammation in irritable bowel syndrome?

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Effect of maternal probiotic intervention on HPA axis, immunity and gut microbiota in a rat model of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Role of nerve growth factor in the trinitrobenzene sulfonic acid-induced colonic hypersensitivity

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Interactive involvement of brain derived neurotrophic factor, nerve growth factor, and calcitonin gene related peptide in colonic hypersensitivity in the rat.

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Pregabalin (CI-1008) inhibits the trinitrobenzene sulfonic acid-induced chronic colonic allodynia in the rat.

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

The functional gastrointestinal disorders and the Rome III process

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Rome III: the new criteria

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

AGA technical review on irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Cytokines mediating the induction of chronic colitis and colitis-associated fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

4SC-101, a novel immunosuppressive drug, inhibits IL-17 and attenuates colitis in two murine models of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

The IL-23/IL-17 pathway in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Stress-induced visceral hypersensitivity to rectal distension in rats: role of CRF and mast cells.

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Psychometric scores and persistence of irritable bowel after infectious diarrhoea.

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Sensory neuro-immune interactions differ between irritable bowel syndrome subtypes

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Fermented milk containing Lactobacillus casei strain Shirota prevents the onset of physical symptoms in medical students under academic examination stress.

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Irritable bowel syndrome, gut microbiota and probiotics.

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Definition and classification of irritable bowel syndrome: current consensus and controversies

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Functional bowel disorders

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Genetic heterogeneity and functional properties of intestinal bifidobacteria

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study.

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Visceral pain: a review of experimental studies

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Immunomodulation of enteric neural function in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Effect of GABA(B) receptor agonist on distension-sensitive pelvic nerve afferent fibers innervating rat colon

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Guidelines on the irritable bowel syndrome: mechanisms and practical management.

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Repeated, but not acute, stress suppresses inflammatory plasma extravasation

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Are there any different effects of Bifidobacterium, Lactobacillus and Streptococcus on intestinal sensation, barrier function and intestinal immunity in PI-IBS mouse model?

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Pro-inflammatory miR-223 mediates the cross-talk between the IL23 pathway and the intestinal barrier in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Changes of cytokine levels in a mouse model of post-infectious irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Ethical guidelines for investigations of experimental pain in conscious animals

1 reference

https://api.crossref.org/works/10.1111%2FJAM.13320

21 January 2018

Identifiers

10.1111/JAM.13320

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27718511%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27718511%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48313903&oldid=2066123340"